Recent News
Press Releases
21-12-2021 14:07
Rapid antigen testing units – 22 December 2021
Based on the decisions of the Council of Ministers, and aiming at the suppression of the dispersion of the virus SARS-CoV-2, in places where SafePass is required, individuals aged 6 and above must hold one of the following:Certificate of full vaccination.Proof that they have been infected with COVID-19 during the last six months.Certificate of a negative rapid antigen test, valid for 7 days, for individuals aged 6-11 years old.Certificate of a negative PCR or rapid antigen test, valid fo...
21-12-2021 13:48
Intra & Extra EU Trade Statistics (by commodity and country), January – September 2021
The Statistical Service of Cyprus announces that it has published the monthly electronic publication “Intra & Extra EU Trade Statistics (by commodity and country)” for January – September 2021. It includes detailed quantity and value data on imports and exports of domestically produced goods and foreign goods, classified at the 6 digits commodity code level and by partner country.The main developments in the foreign trade of Cyprus were:(a) Total imports of goods (from EU Member States...
21-12-2021 13:28
Tourist Arrivals: November 2021
The arrivals of tourists reached 148.973 in November 2021 compared to 8.952 in November 2020 and to 169.392 tourist arrivals in November 2019.For the period of January – November 2021, arrivals of tourists totaled 1.840.003 compared to 621.927 in the corresponding period of 2020, recording an increase of 195,9%, and a decrease of 52,4% compared to the period of January – November 2019 (3.866.447 arrivals).Arrivals from the United Kingdom were the main source of tourism for November 2021, wi...
21-12-2021 09:02
Nuvaxovid COVID-19 vaccine (recombinant, adjuvanted)
What is Nuvaxovid and what is it used for?Nuvaxovid is a vaccine for preventing coronavirus disease 2019 (COVID-19) in people aged 18 years and older.Nuvaxovid contains a version of a protein found on the surface of SARS-CoV-2 (the spike protein), which has been produced in the laboratory.Detailed information about this vaccine is available in the product information, which includes the package leaflet.How is Nuvaxovid used?Nuvaxovid is given as two injections, usually into the muscle of...
20-12-2021 20:47
Photo Album - PoR – Award ceremony of the Innovation and Research Awards of OEB
The President of the Republic, Mr Nicos Anastasiades, addresses the award ceremony of the Cyprus Innovation and Research Awards of the Cyprus Employers & Industrialists Federation (OEB), at Strovolos Municipal Theatre, Lefkosia.
20-12-2021 19:38
Photo Album - Health Minister – Scientific Advisory Committee
The Minister of Health, Mr Michalis Hadjipantela, at a meeting with the members of the Scientific Advisory Committee for coronavirus, at the Ministry of Health.
20-12-2021 18:54
Temporary operation of Latsia Vaccination Centre only for scheduled appointments
The Ministry of Health informs the public that as of Wednesday, December 22nd, the Vaccination Centre at the Latsia Health Centre will operate on the following basis:Only after having scheduled an appointment via the Vaccination Portal for a third dose vaccination with the Moderna or Pfizer-BioNTech vaccine.Walk-in only for a scheduled vaccination with the second dose of the Moderna or Pfizer-BioNTech vaccine, provided that the first dose was administered at the Latsia Health Centre.Vacci...
20-12-2021 17:59
Free of charge COVID-19 self-tests for citizens, as of 21 December
The Ministry of Health informs that the free distribution of self-test kits from the pharmacies will start on Tuesday, 21 December and citizens can receive the package of five self-tests within a period of one month from the start of the procedure, just once. Through the process of the rapid antigen self-tests, citizens will be able to protect both their health and that of their loved ones.Beneficiaries are the citizens who have completed their vaccination scheme with two doses for the two-d...
20-12-2021 15:00
EMA recommends Nuvaxovid for authorisation in the EU
EMA has recommended granting a conditional marketing authorisation for Novavax’s COVID-19 vaccine Nuvaxovid (also known as NVX-CoV2373) to prevent COVID-19 in people from 18 years of age.Nuvaxovid is the fifth vaccine recommended in the EU for preventing COVID-19. It is a protein-based vaccine and, together with the already authorised vaccines, will support vaccination campaigns in EU Member States during a crucial phase of the pandemic.After a thorough evaluation, EMA’s human medicines com...
20-12-2021 14:01
Rapid antigen testing units – 21 December 2021
Based on the decisions of the Council of Ministers, and aiming at the suppression of the dispersion of the virus SARS-CoV-2, in places where SafePass is required, individuals aged 6 and above must hold one of the following:Certificate of full vaccination.Proof that they have been infected with COVID-19 during the last six months.Certificate of a negative rapid antigen test, valid for 7 days, for individuals aged 6-11 years old.Certificate of a negative PCR or rapid antigen test, valid fo...
PRESS AND INFORMATION OFFICE
